We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Regions Financial
RF
$26.3B
| $9.65M | 0.04% |
478,073
+187,384
| +64% | +$4.05M |
|
502
Kontoor Brands
KTB
$4.62B
| $9.65M | 0.04% |
170,994
+159,268
| +1,358% | +$9.77M |
|
|
ARVL
503
DELISTED
Arrival Ordinary Shares
ARVL
| $9.62M | 0.04% |
+12,273
| New | +$10.9M |
|
|
YAC
504
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
| $9.58M | 0.04% |
970,682
+41,048
| +4% | +$405K |
|
505
Madrigal Pharmaceuticals
MDGL
$12.6B
| $9.56M | 0.04% |
+98,180
| New | +$11.6M |
|
506
Gold Fields
GFI
$29.2B
| $9.55M | 0.04% |
+1,073,168
| New | +$11.1M |
|
507
Alaska Air
ALK
$5.15B
| $9.53M | 0.04% |
158,015
+148,543
| +1,568% | +$10M |
|
508
Omega Healthcare
OHI
$15.4B
| $9.51M | 0.04% |
262,020
-183,215
| -41% | -$6.8M |
|
509
Kimberly-Clark
KMB
$36.4B
| $9.51M | 0.04% |
+71,060
| New | +$9.48M |
|
510
TaskUs
TASK
$506M
| $9.45M | 0.04% |
+275,861
| New | +$8.71M |
|
|
SIX
511
DELISTED
Six Flags Entertainment Corp.
SIX
| $9.43M | 0.04% |
+217,909
| New | +$9.83M |
|
512
Spectral AI
MDAI
$52.2M
| $9.42M | 0.04% |
+971,055
| New | +$9.43M |
|
513
Agnico Eagle Mines
AEM
$72.6B
| $9.4M | 0.04% |
155,491
+146,791
| +1,687% | +$9.8M |
|
514
Under Armour Class C
UA
$2.92B
| $9.28M | 0.04% |
499,585
-1,392,919
| -74% | -$26.2M |
|
|
AILE
515
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $9.22M | 0.04% |
+955,792
| New | +$9.25M |
|
|
CVII
516
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $9.21M | 0.04% |
+946,305
| New | +$9.27M |
|
|
BBLN
517
DELISTED
Babylon Holdings Limited
BBLN
| $9.19M | 0.04% |
+37,137
| New | +$9.12M |
|
|
PAYOW
518
CALL
DELISTED
Payoneer Global Inc. Warrant
PAYOW
| $9.16M | 0.04% |
+883,252
| New | +$2.23M |
|
519
STMicroelectronics
STM
$46B
| $9.15M | 0.04% |
+251,638
| New | +$9.41M |
|
520
Altimmune
ALT
$539M
| $9.15M | 0.04% |
+928,716
| New | +$12.7M |
|
|
ALBO
521
DELISTED
Albireo Pharma Inc
ALBO
| $9.14M | 0.04% |
259,907
-220,160
| -46% | -$7.16M |
|
|
DOMA
522
DELISTED
Doma Holdings, Inc.
DOMA
| $9.06M | 0.04% |
36,334
| – | – |
|
523
LXP Industrial Trust
LXP
$3.53B
| $9M | 0.04% |
+150,695
| New | +$9.17M |
|
524
UBS Group
UBS
$170B
| $8.96M | 0.04% |
584,793
-980,090
| -63% | -$15.5M |
|
525
Coca-Cola
KO
$354B
| $8.95M | 0.04% |
165,410
-79,909
| -33% | -$4.35M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.